(Q53237344)

12 May 2018

title

Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes. (English)

1 reference

12 May 2018

16

Gianluca Gaidano

1 reference

12 May 2018

21

Giuseppe Saglio

1 reference

12 May 2018

author name string

Patrizia Falco

1

1 reference

12 May 2018

Alessandro Levis

2

1 reference

12 May 2018

Alessandra Stacchini

3

1 reference

12 May 2018

Maria M Ciriello

4

1 reference

12 May 2018

Massimo Geuna

5

1 reference

12 May 2018

Patrizia Notari

6

1 reference

12 May 2018

Paola Omedè

7

1 reference

12 May 2018

Marisa Pautasso

8

1 reference

12 May 2018

Giuseppina Prato

9

1 reference

12 May 2018

Giuliana Strola

10

1 reference

12 May 2018

Daniela Gioia

11

1 reference

12 May 2018

Margherita Bonferroni

12

1 reference

12 May 2018

Gianni Cametti

13

1 reference

12 May 2018

Dario Ferrero

14

1 reference

12 May 2018

Roberto Freilone

15

1 reference

12 May 2018

Carlo Marinone

17

1 reference

12 May 2018

Filippo Marmont

18

1 reference

12 May 2018

Berardino Pollio

19

1 reference

12 May 2018

Flavia Salvi

20

1 reference

12 May 2018

Mauro Girotto

22

1 reference

12 May 2018

Piedmont MDS Registry--Italy

23

1 reference

12 May 2018

publication date

11 August 2011

1 reference

12 May 2018

European Journal of Haematology

published in

1 reference

12 May 2018

volume

87

1 reference

12 May 2018

issue

5

1 reference

12 May 2018

page(s)

409-418

1 reference

12 May 2018

Bone marrow lymphocyte subsets in myelodysplastic syndromes

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

High Ia (HLA-DR) and low CD11b (Mo1) expression may predict early conversion to leukemia in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Immunophenotypic clustering of myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Impact of immunophenotype on prognosis of patients with myelodysplastic syndromes. Its value in patients without karyotypic abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Immunophenotyping of acute leukemias and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Diagnostic flow cytometry for low-grade myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Myelodysplastic syndrome: a search for minimal diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Immunotyping of blasts in refractory anaemia with excess of blasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01676.X

10.1111/J.1600-0609.2011.01676.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018